Showing results 1 to 20 of 86
next >
| Issue Date | Title | Author(s) |
| 2022-01-01 | A new era in oxygen therapeutics? From perfluorocarbon systems to haemoglobin-based oxygen carriers | Charbe, NB; Castillo, F; Tambuwala, MM; Prasher, P; Chellappan, DK; Carreño, A; Satija, S; Singh, SK; Gulati, M; Dua, K; González-Aramundiz, JV; Zacconi, FC |
| 2021-08 | A novel nano therapeutic using convalescent plasma derived exosomal (CPExo) for COVID-19: A combined hyperactive immune modulation and diagnostics | Anand, K; Vadivalagan, C; Joseph, JS; Singh, SK; Gulati, M; Shahbaaz, M; Abdellattif, MH; Prasher, P; Gupta, G; Chellappan, DK; Dua, K |
| 2022-04-28 | A sojourn into therapeutic and nutraceutical potential of curcumin and its novel drug delivery system: Current achievements and future perspectives | Khursheed, R; Singh, SK; Wadhwa, S; Gulati, M; Jha, NK; Gupta, G; Prasher, P; Devkota, HP; Chellappan, DK; Dua, K |
| 2021-02-04 | Activation of TWEAK/Fn14 signaling suppresses TRAFs/NF-κB pathway in the pathogenesis of cancer | Gupta, G; Kazmi, I; Al-Abbasi, FA; Singh, Y; S, R; Rani, S; Mishra, A; Prasher, P; Jha, NK; Thangavelu, L; Dureja, H; Singh, SK; Bhatt, S; Chellappan, DK; Dua, K |
| 2023-01-02 | ADENOCARCINOMA - SUCCESS SO FAR AND THE WAY AHEAD | Fatima, R; Sharma, M; Prasher, P; Gupta, G; Singh, SK; Gulati, M; Dua, K |
| 2020-11 | Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis | Mehta, M; Prasher, P; Sharma, M; Shastri, MD; Khurana, N; Vyas, M; Dureja, H; Gupta, G; Anand, K; Satija, S; Chellappan, DK; Dua, K |
| 2021-05-05 | Advanced drug delivery systems targeting NF-κB in respiratory diseases | Prasher, P; Sharma, M; Chellappan, DK; Gupta, G; Jha, NK; Singh, SK; MacLoughlin, R; Pinto, TJA; Lobenberg, R; Dua, K |
| 2022-07-01 | Advances and applications of dextran-based nanomaterials targeting inflammatory respiratory diseases | Prasher, P; Sharma, M; Singh, SK; Haghi, M; McLoughlin, R; Chellappan, DK; Gupta, G; Paudel, KR; Hansbro, PM; Oliver, BGG; Wich, PR; Dua, K |
| 2022-08 | Advances and applications of monoolein as a novel nanomaterial in mitigating chronic lung diseases. | Chan, Y; Singh, SK; Gulati, M; Wadhwa, S; Prasher, P; Kumar, D; Kumar, AP; Gupta, G; Kuppusamy, G; Haghi, M; George Oliver, BG; Adams, J; Chellappan, DK; Dua, K |
| 2022-05-06 | Advances in designing of polymeric micelles for biomedical application in brain related diseases. | Kaur, J; Gulati, M; Kapoor, B; Jha, NK; Gupta, PK; Gupta, G; Chellappan, DK; Devkota, HP; Prasher, P; Ansari, MS; Aba Alkhayl, FF; Arshad, MF; Morris, A; Choonara, YE; Adams, J; Dua, K; Singh, SK |
| - | Advances in Lung Cancer Treatment Using Nanomedicines | Sharma, A; Shambhwani, D; Pandey, S; Singh, J; Lalhlenmawia, H; Kumarasamy, M; Singh, SK; Chellappan, DK; Gupta, G; Prasher, P; Dua, K; Kumar, D |
| 2020-01 | Albumin Nano-Encapsulation of Piceatannol Enhances Its Anticancer Potential in Colon Cancer Via Downregulation of Nuclear p65 and HIF-1α. | Aljabali, AAA; Bakshi, HA; Hakkim, FL; Haggag, YA; Al-Batanyeh, KM; Al Zoubi, MS; Al-Trad, B; Nasef, MM; Satija, S; Mehta, M; Pabreja, K; Mishra, V; Khan, M; Abobaker, S; Azzouz, IM; Dureja, H; Pabari, RM; Dardouri, AAK; Kesharwani, P; Gupta, G; Dhar Shukla, S; Prasher, P; Charbe, NB; Negi, P; Kapoor, DN; Chellappan, DK; Webba da Silva, M; Thompson, P; Dua, K; McCarron, P; Tambuwala, MM |
| 2021-02-24 | An overview of vaccine development for COVID-19 | Shahcheraghi, SH; Ayatollahi, J; Aljabali, AA; Shastri, MD; Shukla, SD; Chellappan, DK; Jha, NK; Anand, K; Katari, NK; Mehta, M; Satija, S; Dureja, H; Mishra, V; Almutary, AG; Alnuqaydan, AM; Charbe, N; Prasher, P; Gupta, G; Dua, K; Lotfi, M; Bakshi, HA; Tambuwala, MM |
| - | Applications and practice of advanced drug delivery systems for targeting Toll-like receptors in pulmonary diseases | Chan, Y; Prasher, P; Löbenberg, R; Gupta, G; Singh, SK; Oliver, BG; Chellappan, DK; Dua, K |
| 2020-08-20 | Are Medicinal Plants an Alternative Strategy to Combat COVID-19? | Prasher, P; Sharma, M; Gupta, G; Chellappan, DK; Dua, K |
| 2020-01 | Beyond the Obvious: Smoking and Respiratory Infection Implications on Alzheimer's Disease. | Wadhwa, R; Paudel, KR; Mehta, M; Shukla, SD; Sunkara, K; Prasher, P; Panth, N; Goyal, R; Chellappan, DK; Gupta, G; Hansbro, PM; Aljabali, AAA; Tambuwala, MM; Dua, K |
| 2021-10-01 | Can dextran-based nanoparticles mitigate inflammatory lung diseases? | Prasher, P; Sharma, M; R Wich, P; Jha, NK; Singh, SK; Chellappan, DK; Dua, K |
| 2022 | Chapter 13 Advanced drug delivery systems to treat Huntington’s disease: challenges and opportunities | Vishwas, S; Gulati, M; Khursheed, R; Arya, KR; Singh, SK; Jha, NK; Prasher, P; Kumar, D; Kumar, V |
| 2021-01-01 | Chapter 15 Novel Controlled Release Pulmonary Drug Delivery Systems: Current updates and Challenges | Dhanjal, DS; Mehta, M; Chopra, C; Singh, R; Sharma, P; Chellappan, DK; Tambuwala, MM; Bakshi, HA; Aljabali, AAA; Gupta, G; Nammi, S; Prasher, P; Dua, K; Satija, S |
| 2021-01-01 | Chapter 28 Advancements on microparticles-based drug delivery systems for cancer therapy | Verma, D; Bhatia, A; Chopra, S; Dua, K; Prasher, P; Gupta, G; Tambuwala, MM; Chellappan, DK; Aljabali, AAA; Sharma, M; Kapoor, DN |
